Table 1. Frequency of genomic alterations determined by CGH analysis in female ACI rat E2-induced mammary tumors.
Chromosome | Genetic alteration | Region* | Locus* | Ratio† | Frequency, % | P value‡ |
---|---|---|---|---|---|---|
1 | q11-q22 | 1q21-22 | Ccne1 | 7/11 | 63.6 | 0.017 |
4§ | q41-q44 | 4q32-44 | Ccnd2 | 7/11 | 63.6 | 0.005 |
7§ | q31-q33 | 7q33 | c-myc | 9/11 | 81.9 | 0.005 |
9 | q11-q13 | 6/11 | 54.5 | 0.056 | ||
11§ | p-q11 | 6/11 | 54.5 | 0.056 | ||
13§ | q | 7/11 | 63.6 | 0.017 | ||
20§ | p12 | 9/11 | 81.9 | 0.005 |
Eleven individual MTs were examined with an average of 10 metaphases per MT.
From Entrez Genome, Ratus norvegicus Map View (www.ncbi.nlm.nih.gov/mapview/maps.cgi).
Frequencies ≥30%.
Analyzed by binomial distribution.
Chromosomal alterations identified by karyotype analysis.